# Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

> **NCT04025437** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Guangxi Medical University** · enrollment: 214 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** Hepatectomy alone
- **RADIATION:** Neoadjuvant radiotherapy

## Key facts

- **NCT ID:** NCT04025437
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04025437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04025437, "Neoadjuvant Radiotherapy for HCC Involving Type I PVTT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04025437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*